Nutrien Ltd. (NYSE:NTR; TSX:NTR) shares recovered most of an early 5.2% decline on Monday, as investors digested a proposed U.S. purchase of potash from Belarus that lacked specific commercial terms. The stock was trading at $75.52 by 12:22 p.m. Eastern, down $1.57 from Friday's close, after touching a low of $73.07 earlier in the session.
The catalyst for the initial selloff was an announcement by President Donald Trump regarding talks for a U.S. purchase of lower-priced potash from Belarus. However, the proposal did not disclose key details such as price, volume, delivery dates, or logistics. This lack of specificity became the focus of market attention, as traders reassessed the potential impact on global potash prices.
Nutrien's own sensitivity analysis provides a framework for understanding the potential impact. According to its 2026 guidance, a $25-per-tonne change in potash prices would shift annual adjusted EBITDA by approximately $280 million and adjusted earnings by $0.45 per share. This underscores the significance of even modest price movements for the company's financial performance.
Market Reaction Across Fertilizer Sector
Other fertilizer stocks also experienced volatile trading, with many recovering from steeper lows. The Mosaic Company (NYSE:MOS) and Intrepid Potash, Inc. (NYSE:IPI) both rebounded from their session lows. CF Industries Holdings, Inc. (NYSE:CF), primarily a nitrogen producer, served as a broader fertilizer benchmark, trading at $125.17, down 1.98%.
The rebound in the session reflected a counterargument to the initial shock. Traders had priced in a potential supply disruption, but as no concrete commercial terms emerged, the discount narrowed. A proposed purchase does not equate to incremental tonnage in the market, suggesting the initial reaction may have been overdone.
Nutrien's Strong Q2 Performance
Nutrien entered the debate with a robust potash pricing backdrop. In its second-quarter results released on August 5, the company reported potash net sales of $1.053 billion, up 6.3% year-over-year, despite a 1.2% decline in sales volume to 3.943 million tonnes. The average net selling price rose 7.7% to $267 per tonne, while gross margin improved 11.6% to $154 per tonne.
This pricing strength drove potash adjusted EBITDA up $28 million to $658 million, a 4.4% increase. CEO Ken Seitz highlighted record first-half potash sales volumes, and the company raised the low end of its 2026 sales-volume guidance to 14.2 million tonnes.
Analyst Views and Future Outlook
Analysts were already divided on Nutrien's prospects before Monday's announcement. Recent price targets range from $63 to $81, reflecting both upside and downside from the current price of $75.52. Morgan Stanley's Vincent Sinisi holds an Overweight rating with a target of $81, while Jefferies' Laurence Alexander has a Hold rating with a target of $63.
The market has largely erased the initial shock, but the earnings question remains. Sustained discounted imports could pressure realized North American prices, but only if the proposed deal translates into actual, significant tonnage. Risks include a signed, large, and deliverable Belarus contract that could reset regional prices, or a small or delayed purchase that could make Monday's remaining discount excessive.
Investors will look to Nutrien's November 5 third-quarter earnings call for further clarity. In the meantime, the key missing fact is the actual volume of potash the proposed U.S. deal would deliver. Until then, the market's reaction will likely remain muted, as the headline lacks the substance needed to alter long-term expectations.
